#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liver transplant rejection Squamous cell carcinoma of the cervix Familial dilated cardiomyopathy Salivary gland cancer Carcinoid syndrome Anaplastic thyroid cancer Extra-osseous Ewing's sarcoma B-cell small lymphocytic lymphoma refractory Gastrointestinal stromal tumour Non-renal cell carcinoma of kidney Huntington's disease Squamous cell carcinoma of the hypopharynx Gastric cancer Ovarian cancer stage III Inborn error of metabolism More trials…

    Learn about Rare Diseases

    Testicular leiomyosarcoma – Life with Disease Malignant fibrous histiocytoma – Life with Disease Urea cycle disorder – Life with Disease Atypical haemolytic uraemic syndrome – Diagnostics Rhabdoid tumour Synovial sarcoma recurrent – Trials in Disease Hereditary motor and sensory neuropathy – Treatment Osteosarcoma – Trials in Disease Primary immunodeficiency syndrome – Basic Information Paraneoplastic neurological syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GOCATAMIG 68Ganota-Anti-Her2 Vhh1 Mirodenafil Dihydrochloride Zidovudine Lactic Acid 2-DEOXY-D-GLUCOSE Tumour Detection Ecoo75 Mebufotenin Gtaexs617 Etanercept Aficamten Allo-501A RIVASTIGMINE Azd3470 Alizapride F770/05 Bdc-1001 Apixaban Clascoterone More therapies…

    Learn about Your Condition

    Paresis Cardiovascular disorder Cortisol abnormal Metabolic surgery Congenital myopathy Foetal growth restriction Haemorrhoids Desmoplastic melanoma Seasonal allergy Hypertrophic scar Brain abscess Aortic disorder Bladder cancer Endocrine disorder Patent ductus arteriosus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Eplerenone for Improving Kidney Function in Patients Undergoing Kidney Transplantation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Eplerenone
    • Iohexol
    France

  • Study on Ethinylestradiol/Levonorgestrel and Vitamin E for Treating Menstrual and Perimenopausal Migraines in Women

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Alpha-Tocopherol
    • Ethinylestradiol
    • Levonorgestrel
    The Netherlands

  • Study Comparing Atezolizumab Alone and Atezolizumab with Bevacizumab for First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    Italy

  • Study on Statins for Frail Older Patients with Recent Ischemic Stroke or TIA: Fluvastatin, Simvastatin, Pravastatin Sodium, Atorvastatin, and Rosuvastatin Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Fluvastatin
    • Simvastatin
    • Atorvastatin
    The Netherlands

  • Study on Olaparib for Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Olaparib
    Italy

  • Study on Letrozole vs. Chemotherapy (Carboplatin and Paclitaxel) for Patients with Advanced Low-Grade Serous Ovarian Cancer with Hormone Receptors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer stage IV
    • Ovarian cancer stage III
    Investigated Drugs:
    • Carboplatin
    • Letrozole
    • Paclitaxel
    Czechia Italy
Previous Page
1 … 299 300 301 302 303 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!